Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity BIOTRON LIMITED ABN/ARBN Financial year ended: 60 086 399 144 30 June 2026 Our...
Appendix 4G
Filed with ASX · · 13 pages · English
On 6ix: 6ix.com/news/appendix-4g-17
Release
Earlier from Biotron
- Corporate Governance Statement
- Full Year Statutory Accounts and Appendix 4E
- Change in substantial holding
- HBV Treatment to Progress Towards Human Trials
- Sedarex First Milestone Met
Later from Biotron
- Investor Presentation
- Change of Share Registry
- Resignation of Managing Director and Appendix 3Z
- Appointment of CEO and Executive Director
- Director Appointment Michael Thurn & Appendix 3X
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron